Adenovirus IL-13-induced airway disease in mice: A corticosteroid-resistant model of severe asthma

American Journal of Respiratory Cell and Molecular Biology

Volumn 39, Issue 1, 2008, Pages 26-35

  Therien, Alex G ^a,b   Bernier, Virginie ^a,c   Weicker, Sean ^a   Tawa, Paul ^a   Falgueyret, Jean Pierre ^a   Mathieu, Marie Claude ^a   Honsberger, Jeanne ^a   Pomerleau, Véronique ^a   Robichaud, Annette ^a,d   Stocco, Rino ^a   Dufresne, Lynn ^a   Houshyar, Hani ^a   Lafleur, Josiane ^a   Ramachandran, Chidambaram ^a,e   O'Neill, Gary P ^a   Slipetz, Deborah ^a   Tan, Christopher M ^a  

^a MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Servier Canada Inc   (Canada)

^d SCIREQ   (Canada)

^e AMGEN INC   (United States)

Author keywords

Asthma; Corticosteroids; IL 13; Neutrophils; Proteomic

Indexed keywords

CORTICOSTEROID; INTERLEUKIN 13; OVALBUMIN; STAT PROTEIN;

ADENOVIRUS; ALLERGIC PNEUMONITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BRONCHUS MUCUS; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PROTEIN EXPRESSION; PROTEOMICS;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; AIRWAY OBSTRUCTION; ANIMALS; CELL CULTURE TECHNIQUES; CELL DIVISION; DISEASE MODELS, ANIMAL; INTERLEUKIN-13; MALE; MICE; MICE, INBRED BALB C; MUCUS; OVALBUMIN; RESPIRATORY FUNCTION TESTS; RESPIRATORY MUCOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ADENOVIRIDAE; MURINE ADENOVIRUS 1; MUS;

EID: 45849098658     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2007-0240OC     Document Type: Article

References (49)

1. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999;17:255-281.
2. Ngoc LP, Gold DR, Tzianabos AO, Weiss ST, Celedon JC. Cytokines, allergy, and asthma. Curr Opin Allergy Clin Immunol 2005;5:161-166.
3. Elias JA, Zheng T, Lee CG, Homer RJ, Chen Q, Ma B, Blackburn M, Zhu Z. Transgenic modeling of interleukin-13 in the lung. Chest 2003;123:339S-345S.
4. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, Zhang Y, Elias JA. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999;103:779-788.
5. Walter DM, McIntire JJ, Berry G, McKenzie AN, Donaldson DD, DeKruyff RH, Umetsu DT. Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J Immunol 2001;167:4668-4675.
6. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD. Interleukin-13: central mediator of allergic asthma. Science 1998;282:2258-2261.
7. Yang G, Volk A, Petley T, Emmell E, Giles-Komar J, Shang X, Li J, Das AM, Shealy D, Griswold DE, et al. Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling. Cytokine 2004;28:224-232.
8. Humbert M, Durham SR, Kimmitt P, Powell N, Assoufi B, Pfister R, Menz G, Kay AB, Corrigan CJ. Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J Allergy Clin Immunol 1997;99:657-665.
9. Prieto J, Lensmar C, Roquet A, van der Ploeg I, Gigliotti ID, Eklund A, Grunewald J. Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocations. Respir Med 2000;94:806-814.
10. Hoffjan S, Nicolae D, Ober C. Association studies for asthma and atopic diseases: a comprehensive review of the literature. Respir Res 2003;4:14.
11. Vercelli D. Genetics of IL-13 and functional relevance of IL-13 variants. Curr Opin Allergy Clin Immunol 2002;2:389-393.
12. Vladich FD, Brazille SM, Stern D, Peck ML, Ghittoni R, Vercelli D. IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation. J Clin Invest 2005;115:747-754.
13. Rosenecker J, Huth S, Rudolph C. Gene therapy for cystic fibrosis lung disease: current status and future perspectives. Curr Opin Mol Ther 2006;8:439-445.
14. Youil R, Toner TJ, Su Q, Casimiro D, Shiver JW, Chen L, Bett AJ, Rogers BM, Burden EC, Tang A, et al. Comparative analysis of the effects of packaging signal, transgene orientation, promoters, polyadenylation signals, and E3 region on growth properties of first-generation adenoviruses. Hum Gene Ther 2003;14:1017-1034.
15. Nakanishi A, Morita S, Iwashita H, Sagiya Y, Ashida Y, Shirafuji H, Fujisawa Y, Nishimura O, Fujino M. Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma. Proc Natl Acad Sci USA 2001;98:5175-5180.
16. Muruve DA. The innate immune response to adenovirus vectors. Hum Gene Ther 2004;15:1157-1166.
17. Kuperman DA, Huang X, Koth LL, Chang GH, Dolganov GM, Zhu Z, Elias JA, Sheppard D, Erle DJ. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med 2002;8:885-889.
18. Blanchard C, Mishra A, Saito-Akei H, Monk P, Anderson I, Rothenberg ME. Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354). Clin Exp Allergy 2005;35:1096-1103.
19. Eum SY, Maghni K, Hamid Q, Eidelman DH, Campbell H, Isogai S, Martin JG. Inhibition of allergic airways inflammation and airway hyperresponsiveness in mice by dexamethasone: role of eosinophils, IL-5, eotaxin, and IL-13. J Allergy Clin Immunol 2003;111:1049-1061.
20. Wiesmann C, Katschke KJ, Yin J, Helmy KY, Steffek M, Fairbrother WJ, McCallum SA, Embuscado L, DeForge L, Hass PE, et al. Structure of C3b in complex with CRIg gives insights into regulation of complement activation. Nature 2006;444:217-220.
21. Drouin SM, Corry DB, Hollman TJ, Kildsgaard J, Wetsel RA. Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy. J Immunol 2002;169:5926-5933.
22. Taube C, Rha YH, Takeda K, Park JW, Joetham A, Balhorn A, Dakhama A, Giclas PC, Holers VM, Gelfand EW. Inhibition of complement activation decreases airway inflammation and hyperresponsiveness. Am J Respir Crit Care Med 2003;168:1333-1341.
23. Busse WW. Respiratory infections: their role in airway responsiveness and the pathogenesis of asthma. J Allergy Clin Immunol 1990;85:671-683.
24. Johnston SL. Innate immunity in the pathogenesis of virus-induced asthma exacerbations. Proc Am Thorac Soc 2007;4:267-270.
25. Teran LM, Johnston SL, Schroder JM, Church MK, Holgate ST. Role of nasal interleukin-8 in neutrophil recruitment and activation in children with virus-induced asthma. Am J Respir Crit Care Med 1997;155:1362-1366.
26. Kamath AV, Pavord ID, Ruparelia PR, Chilvers ER. Is the neutrophil the key effector cell in severe asthma? Thorax 2005;60:529-530.
27. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistant asthma. Am J Respir Crit Care Med 1999;160:1532-1539.
28. Kim S, Nadel JA. Role of neutrophils in mucus hypersecretion in COPD and implications for therapy. Treat Respir Med 2004;3:147-159.
29. Holtzman MJ, Fabbri LM, O'Byrne PM, Gold BD, Aizawa H, Walters EH, Alpert SE, Nadel JA. Importance of airway inflammation for hyperresponsiveness induced by ozone. Am Rev Respir Dis 1983;127:686-690.
30. Horie T, Ohmori C, Koyama S, Saitoh O, Mutoh T, Okuma A, Okayasu M. Airway hyperresponsiveness after endotoxin inhalation depends on leukocyte infiltration. Tohoku J Exp Med 1988;156:109-120.
31. Kibe A, Inoue H, Fukuyama S, Machida K, Matsumoto K, Koto H, Ikegami T, Aizawa H, Hara N. Differential regulation by glucocorticoid of interleukin-13-induced eosinophilia, hyperresponsiveness, and goblet cell hyperplasia in mouse airways. Am J Respir Crit Care Med 2003;167:50-56.
32. Fulkerson PC, Fischetti CA, Hassman LM, Nikolaidis NM, Rothenberg ME. Persistent effects induced by IL-13 in the lung. Am J Respir Cell Mol Biol 2006;35:337-346.
33. Schuh JM, Blease K, Hogaboam CM. CXCR2 is necessary for the development and persistence of chronic fungal asthma in mice. J Immunol 2002;168:1447-1456.
34. Mohsenin A, Burdick MD, Molina JG, Keane MP, Blackburn MR. Enhanced CXCL1 production and angiogenesis in adenosine-mediated lung disease. FASEB J 2007;21:1026-1036.
35. Kauffman HF, Tamm M, Timmerman JA, Borger P. House dust mite major allergens Der p 1 and Der p 5 activate human airway-derived epithelial cells by protease-dependent and protease-independent mechanisms. Clin Mol Allergy 2006;4:5.
36. Meyts I, Hellings PW, Hens G, Vanaudenaerde BM, Verbinnen B, Heremans H, Matthys P, Bullens DM, Overbergh L, Mathieu C, et al. IL-12 contributes to allergen-induced airway inflammation in experimental asthma. J Immunol 2006;177:6460-6470.
37. Jeong H, Rhim T, Ahn MH, Yoon PO, Kim SH, Chung IY, Uh S, Kim SI, Park CS. Proteomic analysis of differently expressed proteins in a mouse model for allergic asthma. J Korean Med Sci 2005;20:579-585.
38. Zhao J, Yeong LH, Wong WS. Dexamethasone alters bronchoalveolar lavage fluid proteome in a mouse asthma model. Int Arch Allergy Immunol 2007;142:219-229.
39. Roh GS, Shin Y, Seo SW, Yoon BR, Yeo S, Park SJ, Cho JW, Kwack K. Proteome analysis of differential protein expression in allergen-induced asthmatic mice lung after dexamethasone treatment. Proteomics 2004;4:3318-3327.
40. Magi B, Bargagli E, Bini L, Rottoli P. Proteome analysis of bronchoalveolar lavage in lung diseases. Proteomics 2006;6:6354-6369.
41. Wu J, Kobayashi M, Sousa EA, Liu W, Cai J, Goldman SJ, Dorner AJ, Projan SJ, Kavuru MS, Qiu Y, et al. Differential proteomic analysis of bronchoalveolar lavage fluid in asthmatics following segmental antigen challenge. Mol Cell Proteomics 2005;4:1251-1264.
42. Webb DC, McKenzie AN, Foster PS. Expression of the Ym2 lectin-binding protein is dependent on interleukin (IL)-4 and IL-13 signal transduction: identification of a novel allergy-associated protein. J Biol Chem 2001;276:41969-41976.
43. Heinzmann A, Dietrich H, Deichmann KA. Association of uteroglobulin-related protein 1 with bronchial asthma. Int Arch Allergy Immunol 2003;131:291-295.
44. Zhou Y, Dong Q, Louahed J, Dragwa C, Savio D, Huang M, Weiss C, Tomer Y, McLane MP, Nicolaides NC, et al. Characterization of a calcium-activated chloride channel as a shared target of Th2 cytokine pathways and its potential involvement in asthma. Am J Respir Cell Mol Biol 2001;25:486-491.
45. Lenz AG, Hinze-Heyn H, Schneider A, Behr J, Haussinger K, Heindi S, Stanzel F, Maier KL. Influence of inflammatory mechanisms on the redox balance in interstitial lung iseases. Respir Med 2004;98:737-745.
46. Kishore U, Bernal AL, Kamran MF, Saxena S, Singh M, Sarma PU, Madan T, Chakraborty T. Surfactant proteins SP-A and SP-D in human health and disease. Arch Immunol Ther Exp (Warsz) 2005;53:399-417. (Warsz).
47. Hawlisch H, Wills-Karp M, Karp CL, Kohl J. The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma. Mol Immunol 2004;41:123-131.
48. Humbles AA, Lu B, Nilsson CA, Lilly C, Israel E, Fujiwara Y, Gerard NP, Gerard C. A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature 2000;406:998-1001.
49. Katz Y, Stav D, Barr J, Passwell JH. IL-13 results in differential regulation of the complement proteins C3 and factor B in tumour necrosis factor (TNF)-stimulated fibroblasts. Clin Exp Immunol 1995;101:150-156.